HBK INVESTMENTS L P - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$536,653,500
+346.4%
3,550,000
+330.3%
3.87%
+467.2%
Q2 2022$120,210,750
+3331.7%
825,000
+931.2%
0.68%
+2100.0%
Q2 2019$3,503,00080,0000.03%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 857,494$55,746,00045.68%
RP Management, LLC 2,111,111$137,243,00020.57%
ORACLE INVESTMENT MANAGEMENT INC 2,074,800$134,883,00017.78%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,310,261$85,180,0009.56%
TANG CAPITAL MANAGEMENT LLC 599,091$38,947,0007.05%
Blackcrane Capital, LLC 44,112$2,868,0006.69%
ARS Investment Partners, LLC 559,574$36,378,0005.72%
Eversept Partners, LP 321,581$20,905,9814.64%
Avidity Partners Management LP 1,284,200$83,486,0003.87%
ARDSLEY ADVISORY PARTNERS LP 257,000$16,708,0003.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders